Spironolactone Misses Mark in Hemodialysis Trial
Primary results presented at ASN Kidney Week 2023 showed spironolactone missed the trial's primary endpoint.
Source: hcplive.com
Page 2 - Patrick Rossignol News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Patrick Rossignol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Patrick Rossignol Today - Breaking & Trending Today
High-impact clinical trials yield results tha
The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2023 November 1–November 5.
Source: eurekalert.org
Monaco hosts inaugural Heart Day with support of Princess Stephanie
The first Heart Day in Monaco has brought together specialists to raise awareness discuss the latest innovative solutions to treating heart disease, something that kills one in two women globally.
Source: monacolife.net
Fenofibrate improves heart failure outcomes in patients with type 2 diabetes: ACCORD Lipid trial
Porto, Portugal: Recent data from the ACCORD Lipid trial showed that fenofibrate reduces the composite of HF hospitalizations or cardiovascular mortality in type 2 diabetes (T2D) patients treated with...
Source: medicaldialogues.in
RAASis discontinuation causes recurrent hyperkalemia and hospitalization: Study
France: A new study by Patrick Rossignol and the team revealed that recurrent hyperkalemia (HK) is associated with RAASi discontinuation and dose lowering. Among those with recurrent HK, HK is the...
Source: medicaldialogues.in